TWST (STOCKS)
Twist Bioscience Corporation Common Stock
$49.600000
+0.540000 (+1.10%)
Prev close: $49.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Emily Marine Leproust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,043.51M
- Employees
- 923
- P/E (TTM)
- -38.95
- P/B (TTM)
- 6.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$-0.50 | $-0.44 | -0.0614 | -14.00% |
|
Sep 2025 (Q4)
|
$-0.45 | $-0.44 | -0.0122 | -2.79% |
|
Jun 2025 (Q3)
|
$-0.47 | $-0.57 | +0.0999 | +17.53% |
|
Mar 2025 (Q2)
|
$-0.66 | $-0.59 | -0.0727 | -12.38% |
Financial Statements
| Revenues | $391.56M |
| Benefits Costs and Expenses | $467.26M |
| Cost Of Revenue | $189.42M |
| Costs And Expenses | $526.07M |
| Gross Profit | $202.13M |
| Operating Expenses | $336.65M |
| Selling, General, and Administrative Expenses | $260.54M |
| Research and Development | $76.11M |
| Operating Income/Loss | -$134.51M |
| Income/Loss From Continuing Operations After Tax | -$76.58M |
| Income/Loss From Continuing Operations Before Tax | -$75.71M |
| Income Tax Expense/Benefit | $876.00K |
| Net Income/Loss | -$76.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$76.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$76.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.27 |
| Diluted Earnings Per Share | -$1.28 |
| Basic Average Shares | 180,932,000 |
| Diluted Average Shares | 182,101,000 |
| Assets | $638.09M |
| Current Assets | $303.88M |
| Inventory | $32.92M |
| Other Current Assets | $270.96M |
| Noncurrent Assets | $334.20M |
| Fixed Assets | $105.12M |
| Other Non-current Assets | $229.08M |
| Liabilities | $181.99M |
| Current Liabilities | $80.44M |
| Accounts Payable | $12.49M |
| Wages | $18.84M |
| Other Current Liabilities | $49.11M |
| Noncurrent Liabilities | $101.55M |
| Equity | $456.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $456.10M |
| Liabilities And Equity | $638.09M |
| Net Cash Flow From Operating Activities | -$51.01M |
| Net Cash Flow From Operating Activities, Continuing | -$51.01M |
| Net Cash Flow From Investing Activities | -$33.16M |
| Net Cash Flow From Investing Activities, Continuing | -$33.16M |
| Net Cash Flow From Financing Activities | $10.89M |
| Net Cash Flow From Financing Activities, Continuing | $10.89M |
| Exchange Gains/Losses | $205.00K |
| Net Cash Flow | -$73.07M |
| Net Cash Flow, Continuing | -$73.28M |
| Comprehensive Income/Loss | -$76.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$76.49M |
| Other Comprehensive Income/Loss | $78.00K |